Non-ergot dopamine agonist-induced sleep attacks

Melody Ryan, John T. Slevin, Ammie Wells

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.

Original languageEnglish
Pages (from-to)724-726
Number of pages3
Issue number6 I
StatePublished - 2000

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Non-ergot dopamine agonist-induced sleep attacks'. Together they form a unique fingerprint.

Cite this